Australia Ultrasound Devices Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

Market Overview

The Australia ultrasound devices market is a capital equipment and service business in which revenue grows through replacement, upgrades, software and the spread of low-cost handheld probes into new clinical settings. Private radiology groups buy cart-based platforms against Medicare-funded volume, while hospitals and general practices increasingly add portable and handheld units at the bedside.

Three forces shape the outlook: artificial intelligence that guides scanning and automates measurements, a shortage of accredited sonographers that rewards faster workflows, and supplier realignment as global manufacturers reposition their ranges for general imaging, cardiology and procedural care.

In November 2025 the Department of Health, Disability and Ageing closed a consultation on obstetric and pelvic ultrasound fees, and from 1 July 2026 most diagnostic imaging fees were indexed. On 12 October 2026 Siemens Healthineers stopped selling general imaging ultrasound systems.

Key Market Trends and Insights

• Workforce limits: The Australasian Sonographers Association reported in December 2025 that 8,381 accredited medical sonographers were registered at 1 November 2025, which favours faster, more automated scanning systems.
• Obstetric volume: The Medicare consultation paper that closed in November 2025 recorded about 1,160,517 requested obstetric ultrasound services, the most dependable recurring clinical demand in the market.
• Pelvic imaging: The same paper counted 1,127,193 services under general pelvic item 55065, worth about AUD 115.5 million in benefits, so gynaecological scanning anchors replacement demand.
• Fee indexation: From 1 July 2026 the Medicare Benefits Schedule indexed most diagnostic imaging fees by 2.6%, supporting provider revenue and equipment budgets.

Australia Ultrasound Devices Market Size and Forecast

The market is moving from conventional cart-based replacement towards connected platforms with artificial intelligence guidance, wireless probes and cloud-linked workflows. Cart-Based Diagnostic Systems remain the revenue anchor, while Handheld and POCUS Devices add the most momentum. Doppler Imaging leads technology because most purchased systems now include flow assessment, with 3D and 4D Imaging advancing fastest. Radiology and General Imaging holds the largest application share, with Cardiology growing quickest. New South Wales is the largest region and Queensland grows fastest. Equipment finance, probe replacement and software subscriptions support a steady mid-single-digit outlook. Providers also weigh sonographer availability when timing upgrades.

Key Takeaways: Australia Ultrasound Devices Market

Software and Replacement Lift Revenue

Revenue is on course to expand by about 82% across the decade, from AUD 320.00 million in 2025 to AUD 583.98 million in 2035 at a 6.2% CAGR. Indexed fees, artificial intelligence upgrades and equipment renewal make demand recurring.

Handheld Devices and Cardiology Lead Growth

Handheld and POCUS Devices grow at an estimated 11.8% CAGR and 3D and 4D Imaging at 7.8% through 2035. Cardiology advances at 7.1% as echocardiography moves towards guided, bedside scanning.

Workforce and Policy Shape Purchasing

Sonographer scarcity, Medicare fee settings and supplier realignment influence when and where systems are ordered. Vendors that pair hardware with guidance software and service coverage gain bargaining power with large imaging groups and public health services.

• 8,381 accredited sonographers registered at 1 November 2025
• Imaging fees indexed by 2.6% from 1 July 2026
• Siemens Healthineers left general imaging ultrasound on 12 October 2026

Australia Ultrasound Devices Market Report Summary

Key Insight

Medicare-funded obstetric and general imaging, a stretched sonographer workforce and artificial intelligence guidance sustain demand. Handheld devices grow fastest while cart-based platforms keep the largest revenue.

Key Trends in the Australia Ultrasound Devices Market

The Australia ultrasound devices market is being reshaped by supplier realignment, indexed Medicare fees, a review of obstetric and pelvic items and a persistent shortage of sonographers.

October 2026 - Siemens Healthineers Exits General Imaging Ultrasound

• On 12 October 2026 Siemens Healthineers stopped selling general imaging ultrasound, discontinuing the Acuson Sequoia, Redwood, Juniper and Maple systems.
• It retains Acuson Origin for cardiovascular imaging, the P500 intracardiac system and the wireless Freestyle system, focusing on procedural imaging.
• Service, software updates and probes remain available to existing customers, so installed bases in Australia need replacement planning.

July 2026 - Medicare Updates Imaging Fees and Breast Ultrasound Rules

• From 1 July 2026 schedule fees for most diagnostic imaging services were indexed by 2.6%, according to the Medicare Benefits Schedule news notice.
• Restrictions on claiming breast ultrasound with chest or abdominal wall item 55812 were removed, and the multiple services rule no longer applies to breast imaging.
• Multiple imaging services on one referral can now be provided within 14 days, replacing a seven-day limit.

December 2025 - Sonographer Workforce Report Highlights Capacity Limits

• The Australasian Sonographers Association published its workforce report in December 2025, counting 8,381 accredited medical sonographers at 1 November 2025.
• Cardiac sonographers numbered 1,764, or 21% of the register, and about 1,120 accredited student sonographers were recorded.
• The report states sonography has been on the national occupation shortage list for well over a decade, with shortages in every state and territory.

November 2025 - Medicare Reviews Obstetric and Pelvic Ultrasound Items

• The Department of Health, Disability and Ageing closed phase two consultation on select ultrasound services on 28 November 2025, with advice due to government in early 2026.
• The paper proposed separate items for singleton, multiple and monochorionic pregnancies and a new tubal patency item, 55996, at AUD 550.
• Item 55080, a new pelvic ultrasound item, took effect on 1 November 2025.

Key Insight

Supplier realignment, fee indexation and a review of Medicare ultrasound items are reshaping purchasing. Workforce scarcity pushes buyers toward faster, guided systems and wireless probes.

Recent Market Developments in the Australia Ultrasound Devices Market

Recent developments, presented from the most recent, show the Australia ultrasound devices market moving through provider earnings, artificial intelligence launches and new portable and obstetric platforms.

August 2026 - Imaging Groups Report Full-Year Results

• On 25 August 2026 Integral Diagnostics reported revenue up 25.6% to AUD 788.7 million and expects capital expenditure of AUD 50 million to AUD 60 million.
• On 20 August 2026 Sonic Healthcare reported group revenue of AUD 10.87 billion, up 13%, across laboratory and imaging operations in nine countries.
• Large private groups set equipment panels, so their capital plans influence ultrasound replacement across the states.

July 2026 - Philips Launches the Alturion AI Ultrasound System

• On 10 July 2026 Philips announced Alturion, a system with a 24-inch monitor and shared interface with the EPIQ Elite and Affiniti ranges.
• It includes Elevate Plus, which provides artificial intelligence measurements for abdominal ultrasound and supports remote Collaboration Live tele-ultrasound.
• Availability was stated for the United States and Europe, so Australian supply is not yet confirmed.

November 2025 - Fujifilm Sonosite and Samsung Medison Add New Systems

• On 4 November 2025 Fujifilm Sonosite launched Sonosite MT, a clamshell point-of-care system designed for durability and mobility.
• On 24 November 2025 trade press reported that Samsung Medison planned to introduce the R20 at RSNA, with real-time exam guidance and automated measurements.
• Both launches point to guided scanning moving into mid-range and mobile systems.

September 2025 - GE HealthCare Launches Voluson Performance Series

• On 15 September 2025 trade press reported GE HealthCare's launch of the Voluson Performance 18 and 16 women's health ultrasound systems.
• The systems offer wireless Vscan Air probes, voice activation through Hey Voluson and SonoLyst artificial intelligence for fetal anatomy.
• The launch targets obstetric and gynaecological clinics, a segment with heavy Medicare volume.

Key Insight

Manufacturers are adding guidance software, wireless probes and mobile formats while imaging groups report strong earnings. Artificial intelligence is moving from premium platforms into everyday scanners.

Australia Ultrasound Devices Industry Segmentation

The Expert Market Research’s report on the Australia Ultrasound Devices Market offers a detailed analysis of the market based on the following segments.

Market Breakup by Product Type

• Cart-Based Diagnostic Systems
• Compact and Portable Systems
• Handheld and POCUS Devices
• Therapeutic and HIFU Systems
• Others

Cart-Based Diagnostic Systems lead revenue, as GE HealthCare launched its Voluson Performance series in September 2025 and Philips introduced Alturion in July 2026. Compact and Portable Systems serve wards, theatres and regional hospitals, with Fujifilm Sonosite launching Sonosite MT in November 2025. Handheld and POCUS Devices grow fastest at an estimated 11.8% CAGR, although Butterfly Network reported international revenue down 14% in its second-quarter 2026 results, showing uneven export demand. Therapeutic and HIFU Systems cover focused ultrasound for prostate, fibroid and tissue ablation and grow from a smaller base.

Market Breakup by Technology

• 2D Imaging
• 3D and 4D Imaging
• Doppler Imaging
• Contrast-Enhanced and Elastography
• Others

Doppler Imaging leads revenue because cardiac, vascular and obstetric work depends on flow assessment, and Philips added Elevate Plus measurements in July 2026. 2D Imaging remains the base mode in handheld and compact devices but grows slowest. 3D and 4D Imaging grows fastest at an estimated 7.8% CAGR, helped by GE HealthCare's September 2025 Voluson Performance launch. Contrast-Enhanced and Elastography gains from the Medicare consultation of November 2025, which proposed a contrast tubal patency item, 55996, at AUD 550.

Market Breakup by Application

• Radiology and General Imaging
• Cardiology
• Obstetrics and Gynaecology
• Vascular
• Others

Radiology and General Imaging leads revenue, supported by 2.6% fee indexation from 1 July 2026. Cardiology grows fastest at an estimated 7.1% CAGR, with 1,764 cardiac sonographers registered at 1 November 2025 and Siemens Healthineers keeping Acuson Origin for cardiovascular work. Obstetrics and Gynaecology is the heaviest Medicare category, with about 1,160,517 requested obstetric services in the consultation paper closed in November 2025. Vascular benefits from Fujifilm Sonosite's iLOOK vascular access system, announced in July 2026. Others covers musculoskeletal, urology, emergency and anaesthesia use.

Market Breakup by Region

• New South Wales
• Victoria
• Queensland
• Western Australia
• South Australia
• Others

New South Wales dominates through the largest population and private imaging network, growing at an estimated 5.9% CAGR through 2035. Victoria follows at 5.8%, as large groups such as Integral Diagnostics plan AUD 50 million to AUD 60 million of capital expenditure after August 2026 results. Queensland is the fastest-growing region at an estimated 6.9%, helped by population inflow and decentralised care. Western Australia grows at 6.6% as distance favours portable units. South Australia grows at 6.0%. Others covers Tasmania, the ACT and the Northern Territory at 6.3%, where the December 2025 workforce report recorded shortages.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Competitive Landscape in the Australia Ultrasound Devices Market

Competition combines global ultrasound manufacturers with local service teams, and large private imaging groups that buy at scale. Barriers include TGA registration, clinical evidence, probe portfolios, service coverage, software ecosystems and financing terms.

GE HealthCare

GE HealthCare, headquartered in Chicago, Illinois, supplies Voluson, Logiq and Vscan ultrasound systems to Australian hospitals, obstetric clinics and imaging groups. In September 2025 it launched the Voluson Performance 18 and 16, with wireless Vscan Air probes, voice activation and SonoLyst artificial intelligence for fetal anatomy. Australian availability of the new series has not been confirmed. The company also provides service contracts and cloud-linked image management.

Philips

Philips, headquartered in Amsterdam, the Netherlands, supplies EPIQ Elite, Affiniti and Lumify ultrasound products in Australia through Philips Australia in Sydney. On 10 July 2026 it announced the Alturion system with Elevate Plus artificial intelligence measurements, stated as available in the United States and Europe. In June 2026 Philips received United States clearance for Elevate Plus on EPIQ Elite and Affiniti. It also offers tele-ultrasound and service contracts.

Canon Medical Systems

Canon Medical Systems, headquartered in Otawara, Japan, supplies Aplio ultrasound systems in Australia and New Zealand through a regional business. In June 2026 Canon unveiled the Aplio me X at Euroson in Lublin, Poland, a system built on its Altivity artificial intelligence platform with up to four hours of battery operation. Shipping dates and Australian availability were not stated. Canon also supplies training and service to regional hospitals.

Fujifilm Sonosite

Fujifilm Sonosite, headquartered in Bothell, Washington, supplies point-of-care ultrasound for emergency, anaesthesia and critical care. In July 2025 it introduced the UHF46-20, described as the first 46 MHz transducer for point-of-care use, and on 4 November 2025 launched the Sonosite MT clamshell system. In July 2026 it announced the iLOOK system for vascular access. Distribution into Australia runs through its regional sales and service teams.

Other players operating in the Australia ultrasound devices market include Samsung Medison, Mindray, Butterfly Network, Integral Diagnostics, and I-MED Radiology, alongside regional equipment distributors, refurbished system dealers, probe repairers, service providers and imaging software vendors supplying scanners and support across Australia.

Key Insight

Competition rests on image quality, probe range, guidance software, service coverage and financing rather than price alone. Global manufacturers hold scale, while large imaging groups negotiate multi-site agreements.